Congress moves to warn kids about junk food and ban ads targeting them

What it does

This bill requires warning labels on sugar-sweetened beverages, foods with artificial sweeteners, ultra-processed foods, and foods high in added sugar, saturated fat, or sodium. It also bans advertising of these 'junk foods' to children using child-appealing tactics (cartoons, celebrities, influencers, games). The bill funds FDA labeling enforcement, NIH nutrition research, and a CDC public education campaign on healthy eating.

Why we flagged it

The bill's core mechanism is mandatory front-of-package warning labels on certain foods and a ban on child-directed advertising of those foods. It is a consumer-protection and public-health measure, not a tax, subsidy, or commemorative act.

What the text implies

• The definition of 'ultra-processed food' is delegated to FDA regulations (due 1 year after a National Academies report), creating regulatory uncertainty for manufacturers and potential for scope creep or narrowing depending on FDA interpretation.
• The advertising ban applies to 'child-directed advertising' broadly defined—including social media influencers, online videos, and any media where children comprise 30% of the audience. This may capture mainstream advertising and create enforcement complexity.
• The bill requires warning labels on foods with non-sugar sweeteners (aspartame, sucralose, stevia, etc.), which are FDA-approved as safe. This may signal distrust of FDA safety determinations and could confuse consumers about actual risk.
• The FTC is given authority to enforce advertising restrictions on 'common carriers' (telecommunications companies), potentially extending FTC jurisdiction over digital platforms in ways not previously established.

Who it affects

Ordinary citizens—especially parents and children—gain clearer information about food health risks and protection from manipulative marketing targeting minors. The labeling and advertising restrictions are designed to reduce childhood obesity and type 2 diabetes, which are significant public health burdens. The bill does impose compliance costs on food manufacturers, but those costs are passed to consumers only if they choose labeled products; the primary burden falls on industry.

Who stands to gain

• label printing and packaging manufacturers
• nutrition research organizations and universities
• public health advocacy groups
• CDC and NIH (appropriations increase)

Named in the bill

FDA, FTC, NIH, CDC, National Academies of Science, Engineering, and Medicine, food and beverage manufacturers, pharmaceutical companies (BMY, GH, PFE, JNJ, DVA—regulatory exposure)

Where it stands

3 cosponsors: 2 Democrats, 1 Republicans.

• Nov 25, 2025 — Introduced · Congress.gov: “Introduced in House”
• Nov 25, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 lobbying clients named this bill on 2 disclosure filings across 2 quarters, Mar 2026 to Jun 2026. Those filings disclosed $36,700,000 in lobbying spend. A filing names 254 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 0% of bills with at least one filing.

Donald Beyer, the sponsor, reported $633,099 in PAC receipts in the 2026 cycle.

• Chamber of Commerce of the U.S.A. — $36,700,000 on 2 filings

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.